Page last updated: 2024-08-23

almitrine and Cognition Disorders

almitrine has been researched along with Cognition Disorders in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Allain, H; Bentué-Ferrer, D1
Guez, D; Malbezin, M; Piette, F; Poitrenaud, J; Sebban, C2
Guez, D1
Carbonin, PU; Cattelin, F; Gemma, A; Greco, A; Pisanti, P1

Reviews

2 review(s) available for almitrine and Cognition Disorders

ArticleYear
Clinical efficacy of almitrine-raubasine. An overview.
    European neurology, 1998, Volume: 39 Suppl 1

    Topics: Aged; Aging; Almitrine; Clinical Trials as Topic; Cognition Disorders; Drug Combinations; Humans; Ischemia; Neuroprotective Agents; Retinal Vessels; Treatment Outcome; Yohimbine

1998
[Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
    Annales de medecine interne, 1990, Volume: 141 Suppl 1

    Topics: Aged; Aged, 80 and over; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Humans; Piperazines; Psychometrics; Time Factors; Yohimbine

1990

Trials

3 trial(s) available for almitrine and Cognition Disorders

ArticleYear
[Duxil and cognitive deficiency in the elderly. Results of a 6-month controlled multicenter study].
    Annales de medecine interne, 1990, Volume: 141 Suppl 1

    Topics: Aged; Aged, 80 and over; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Humans; Piperazines; Psychometrics; Time Factors; Yohimbine

1990
Almitrine-raubasine and cognitive impairment in the elderly: results of a 6-month controlled multicenter study.
    Clinical neuropharmacology, 1990, Volume: 13 Suppl 3

    Topics: Aged; Aged, 80 and over; Almitrine; Anxiety; Cognition Disorders; Depression; Double-Blind Method; Drug Combinations; Female; Humans; Male; Memory; Psychological Tests; Secologanin Tryptamine Alkaloids; Yohimbine

1990
Efficacy of almitrine-raubasine in cognitive disorders of aging: a double-blind, placebo-controlled, clinical and psychometric study.
    Clinical neuropharmacology, 1990, Volume: 13 Suppl 3

    Topics: Aged; Aged, 80 and over; Aging; Almitrine; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Psychological Tests; Psychometrics; Secologanin Tryptamine Alkaloids; Yohimbine

1990

Other Studies

1 other study(ies) available for almitrine and Cognition Disorders

ArticleYear
Long-term effects and safety of almitrine-raubasine in age-associated cognitive decline.
    Clinical neuropharmacology, 1990, Volume: 13 Suppl 3

    Topics: Aged; Aging; Almitrine; Cognition Disorders; Drug Combinations; Female; Humans; Male; Middle Aged; Secologanin Tryptamine Alkaloids; Time Factors; Yohimbine

1990